General Archive
-
News releases
LifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
News releases
Dr Sam Barrell CBE joins LifeArc as new CEO
We are excited to welcome Dr Sam Barrell, CBE, as she officially joins the LifeArc team today as our new…
-
News releases
LifeArc funds innovative rare liver disease clinical trial
The first patient has been recruited for the FARGO clinical trial, funded by LifeArc and PSC Support, which explores a…
-
Articles & blogs
Bronchiectasis: an overlooked lung condition with untapped commercial and research potential
Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…
-
News releases
Research shows potential ‘life-transforming’ mole reversal therapy in rare condition
Researchers at the Francis Crick Institute, UCL Great Ormond Street Institute for Child Health and Great Ormond Street Hospital for…
-
Articles & blogs
The new LifeArc identity: More than just a fresh coat of paint
In the world of medical research, it’s vital that we keep challenging ourselves to push forwards. We’ve created a new…
-
News releases
New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
LifeArc and ALS Therapy Development Institute (ALS TDI) have joined forces to identify, validate, and develop new biomarkers that are…
-
News releases
LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation
LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London (KCL) to validate a…
-
News releases
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR), which was published today, highlighting the desperate need…
-
Articles & blogs
LifeArc Translational Science Summit: Highlights and key takeaways
The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…
-
News releases
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Great Ormond Street Hospital (GOSH), supported by LifeArc and Great Ormond Street Hospital Children’s Charity (GOSH Charity), is announcing its…